Crospon

From WikiCover

Jump to: navigation, search

Crospon is a medical device company focused on the monitoring and treatment of diabetes and gastroesophageal reflux disorder (GERD). Crospon recently announced the closure of a €2.3 million seed round of financing, which included investment by Enterprise Ireland and The Western Development Commission.

Company founder and chief executive officer John O’Dea, previously co-founded Caradyne, a Galway, Ireland-based respiratory products company that was acquired by Respironics in 2004.

Founded: 2006

Headquarters: Galway, Ireland

Website: http://www.crospon.com/